openPR Logo
Press release

United States Orthobiologics Market Growth Fueled by Sports Injuries & Minimally Invasive Surgeries | Key Players: Stryker, Zimmer Biomet, Arthrex, Inc., Sanofi, Anika Therapeutics, Inc., Ferring, Bioventus LLC

09-29-2025 09:21 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Orthobiologics Market

Orthobiologics Market

The global orthobiologics market size reached US$ 5.45 Billion in 2024 from US$ 5.26 Billion in 2023 and is expected to reach US$ 8.16 Billion by 2033, growing at a CAGR of 4.7% during the forecast period 2025-2033.

The most recent report published by DataM Intelligence indicates that the "Orthobiologics Market" is likely to accelerate significantly in the next few years. The Orthobiologics Market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources.

The Orthobiologics Market study includes information on market factors such as the market dynamics, drivers, restraints, challenges, threats, potential growth opportunities, market trends, development patterns, financial information, latest technologies, innovations, leading competitors, and regional analysis of the market.

Download Latest Sample of This Strategic Report (Get Higher Priority for Corporate Email ID):-@ https://www.datamintelligence.com/download-sample/orthobiologics-market?ophp

The list of Key Players Profiled in the study includes:- Stryker, Zimmer Biomet, Arthrex, Inc., Sanofi, Anika Therapeutics, Inc., Ferring, Bioventus LLC, SeaSpine, and Globus Medical, among others.

United States: Recent Industry Developments

✅ In August 2025, Zimmer Biomet launched a next-generation bone graft substitute incorporating growth factors for orthopedic surgeries.The product aims to accelerate bone healing and improve patient recovery times.

✅ In July 2025, Stryker Corporation announced a $120 million investment to expand its orthobiologics manufacturing facility in Michigan.The expansion will increase production capacity for platelet-rich plasma (PRP) and stem cell-based therapies.

✅ In June 2025, Arthrex introduced a novel injectable orthobiologic solution for tendon and ligament repair.The minimally invasive therapy supports faster tissue regeneration and reduces post-operative complications.

Japan: Recent Industry Developments

✅ In August 2025, Olympus Medical unveiled an advanced scaffold-based orthobiologic implant for spinal fusion procedures in Tokyo.The innovation integrates bioactive materials to enhance osteointegration and patient outcomes.

✅ In July 2025, Teijin Limited partnered with local hospitals to pilot stem cell-derived orthobiologic therapies for cartilage repair.The collaboration targets regenerative treatment options for degenerative joint diseases.

✅ In May 2025, Terumo Corporation launched a next-generation platelet-rich plasma system for orthopedic applications.The system is designed for enhanced growth factor concentration and simplified clinical use in Japan.

Orthobiologics are biologically derived materials, such as platelet-rich plasma, bone grafts, and stem cells, used to repair musculoskeletal injuries. Market growth is driven by aging populations, sports injuries, and minimally invasive procedures. In the U.S., 2025 developments include expanded clinical adoption in outpatient orthopedic centers, new FDA-cleared biologic products, and integration of orthobiologics into enhanced recovery and sports-medicine protocols.

Market Dynamics:

✅Driver: Increasing orthopedic surgeries and demand for biologic solutions for bone and joint repair drive growth.
✅Restraints: High treatment costs and insurance limitations limit patient access.
✅Opportunities: Development of stem-cell-based and growth factor therapies expands the market.
✅Challenges: Standardization issues and variable clinical outcomes remain hurdles.

Segmentation Analysis of the Market:

Global Orthobiologics Market forecast report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market. Orthobiologics Market, By Product Type (Platelet-Rich Plasma (PRP), Bone Morphogenetic Proteins (BMP), Bone Marrow Aspirate (BMA), Bone Marrow Aspirate Concentrate (BMAC), Bone Grafts, Demineralized Bone Matrix (DBM), Stem cells, and Others)
By Application (Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, Maxillofacial & Dental Applications, and Others)
By End User (Hospitals, Orthopedic Clinics, Dental Clinics, and Others)

Research Methodology:

- Primary Research: This method involves collecting new and original data for a specific purpose. Primary research is often conducted through surveys, interviews, focus groups, and observation. It enables researchers to obtain first-hand information directly from the target audience, which is especially useful when researching a new or emerging market.

- Secondary Research: This method involves analyzing and synthesizing existing data from various sources such as industry reports, government publications, academic research, and online databases. Secondary research can provide researchers with valuable insights into industry trends, consumer behavior, and Orthobiologics market size and growth, without the need for extensive data collection.

Most research studies use a combination of both primary and secondary research methods to ensure comprehensive and accurate data analysis. The specific methodology used in a Orthobiologics market research study will depend on various factors such as the research objectives, the target audience, and the available resources.

Request Customized Market Entry Assessment for North America, EU, APAC: https://www.datamintelligence.com/customize/orthobiologics-market?ophp

Regional Outlook:

The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)

South America (Brazil, Argentina, Rest of SA)

Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
The major points covered in the table of contents:

📌 Overview: This part provides a summary of the report, as well as a broad overview of the global Orthobiologics Market, to offer an understanding of the nature and contents of the research study.

📌 Market Analysis: The research forecasts the market share of key segments of the Orthobiologics Market with accuracy and reliability. This study may be used by industry participants to make strategic investments in key growth areas of the Orthobiologics Market.

📌 Analysis of Leading Players' Strategies: This report can be used by market participants to acquire a competitive advantage over their rivals in the Orthobiologics Market.

📌 Regional Growth Analysis: The report covers all of the key areas and countries. The regional analysis will assist market players in tapping into untapped regional markets, developing unique regional strategies, and comparing the growth of all regional markets.

📌 Market Forecasts: Report purchasers will get access to precise and validated estimations of the entire market size in terms of both value and volume. The study also includes estimates for the Orthobiologics Market in terms of consumption, production, sales, and other factors.

Benefits of Orthobiologics Market Reports:

➟ Make informed decisions: The growth of an organization depends on decisions made by management. Using our market research reports, management can make business decisions based on the results obtained that support their knowledge and experience. Orthobiologics Market research helps to understand market trends and is therefore often performed to gain insight into customers.

➟ Get Accurate Information: Our market research provides true and accurate information, preparing organizations for any future mistakes that may occur.

➟ help you choose the right sales system: choose the precise sales system according to the Orthobiologics market demand, to position the product/service in the market.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=orthobiologics-market

The report answers a number of crucial questions, including:

- Which companies dominate the global Orthobiologics market?

- What current trends will influence the market over the next few years?

- What are the market's opportunities, obstacles, and driving forces?

- What predictions for the future can help with strategic decision-making?

- What advantages does market research offer businesses?

Get Corporate Access to Live Orthobiologics Industry Intelligence Database: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Orthobiologics Market Growth Fueled by Sports Injuries & Minimally Invasive Surgeries | Key Players: Stryker, Zimmer Biomet, Arthrex, Inc., Sanofi, Anika Therapeutics, Inc., Ferring, Bioventus LLC here

News-ID: 4201449 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Oligonucleotide Therapy Market Growth Driven by Rare Disease Treat …
The global oligonucleotide therapy market size reached US$ 8.80 Billion in 2024 from US$ 7.51 Billion in 2023 and is expected to reach US$ 40.16 Billion by 2033, growing at a CAGR of 18.6% during the forecast period 2025-2033. The most recent report published by DataM Intelligence indicates that the "Oligonucleotide Therapy Market" is likely to accelerate significantly in the next few years. The Oligonucleotide Therapy Market report gives a purposeful
United States Bispecific MAbs Market Growth Driven by Oncology Innovation & Immunotherapy Adoption | Key Players: Amgen, Genentech / Roche, Genmab, Janssen Biotech, Immunosera Limited
United States Bispecific MAbs Market Growth Driven by Oncology Innovation & Immu …
The global Bi-Specific MAbs market size reached US$ 4.82Billion with rise of US$5.51Billion in 2024 is expected to reach US$ 15.43 Billion by 2033, growing at a CAGR of 15.4%during the forecast period 2025-2033. The most recent report published by DataM Intelligence indicates that the "Bispecific Mabs Market" is likely to accelerate significantly in the next few years. The Bispecific Mabs Market report gives a purposeful depiction of the area by
United States Point of Care Lipid Test Market Expansion Fueled by Cardiovascular Disease Awareness & Rapid Diagnostics | Key Players: Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthcare Private Limited, SD Biosensor, INC.
United States Point of Care Lipid Test Market Expansion Fueled by Cardiovascular …
The global point-of-care (POC) lipid test market reached US$ 0.68 billion in 2023, with a rise to US$ 0.72 billion in 2024, and is expected to reach US$ 1.23 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033. The most recent report published by DataM Intelligence indicates that the "Point of Care Lipid Test Market" is likely to accelerate significantly in the next few years. The
United States Cell Line Development & Bio Production Market Growth Driven by Biologics & Vaccine Manufacturing | Key Players: American Type Culture Collection, Lonza Group AG, Thermo Fisher Scientific Inc, GE Healthcare
United States Cell Line Development & Bio Production Market Growth Driven by Bio …
The Cell line Development Market will grow from USD 5.76 billion in 2024 to USD 13.39 billion by 2033, at a CAGR of 9.9% (2025-2033). The most recent report published by DataM Intelligence indicates that the "Cell Line Development and Bio Production Market" is likely to accelerate significantly in the next few years. The Cell Line Development and Bio Production Market report gives a purposeful depiction of the area by the

All 5 Releases


More Releases for Orthobiologics

Orthobiologics Market Innovations in Regenerative Medicine
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Orthobiologics Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many
Key Orthobiologics Devices And Equipment Market Trend for 2025-2034: Biodegradab …
What Is the Future Outlook for the Orthobiologics Devices And Equipment Market's Size and Growth Rate? In recent times, there has been steady growth in the size of the orthobiologics devices and equipment market. It is projected to rise from $5.74 billion in 2024 to $5.99 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth during the historical period include the introduction of
Key Orthobiologics Devices And Equipment Market Trend for 2025-2034: Biodegradab …
What Is the Future Outlook for the Orthobiologics Devices And Equipment Market's Size and Growth Rate? In recent times, there has been steady growth in the size of the orthobiologics devices and equipment market. It is projected to rise from $5.74 billion in 2024 to $5.99 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth during the historical period include the introduction of
Key Orthobiologics Devices And Equipment Market Trend for 2025-2034: Biodegradab …
What Is the Future Outlook for the Orthobiologics Devices And Equipment Market's Size and Growth Rate? In recent times, there has been steady growth in the size of the orthobiologics devices and equipment market. It is projected to rise from $5.74 billion in 2024 to $5.99 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth during the historical period include the introduction of
Global Orthobiologics Sales Market Report 2017
In this report, the global Orthobiologics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. This report studies Orthobiologics in Global Sales market , especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with sales, price, revenue and market
Orthobiologics Market USD 5.8 Billion by 2020
Orthobiologics Market 2013-2020 report estimates the global orthobiologics market to reach nearly USD 5.8 Billion in 2020, at a CAGR of 6.2% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Orthobiologics Market 2013-2020 report https://www.ihealthcareanalyst.com/report/orthobiologics-market/ The global orthobiologics market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global orthobiologics market segmentation is based on product types (allograft, bone